Jarosław Kaźmierczak

ORCID: 0000-0001-6090-8377
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Cardiomyopathy and Myosin Studies
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular Effects of Exercise
  • Heart Failure Treatment and Management
  • Cardiac Health and Mental Health
  • Health Systems, Economic Evaluations, Quality of Life
  • ECG Monitoring and Analysis
  • Neurological disorders and treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Valve Diseases and Treatments
  • Diabetes Treatment and Management
  • COVID-19 and healthcare impacts
  • Lipoproteins and Cardiovascular Health
  • Inflammatory Myopathies and Dermatomyositis
  • Non-Invasive Vital Sign Monitoring
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Pharmaceutical Economics and Policy
  • Cardiac Structural Anomalies and Repair

Pomeranian Medical University
2016-2025

University of Szczecin
2024

Universitätsmedizin Greifswald
2024

Silesian Center for Heart Disease
2021-2023

Liverpool Heart and Chest Hospital
2023

Liverpool John Moores University
2023

University of Liverpool
2023

Jagiellonian University
2022-2023

Medical University of Warsaw
2023

Medical University of Silesia
2023

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, characterized by an increased risk of thromboembolic complications that can be markedly reduced with anticoagulation. There a paucity studies assessing total prevalence AF in national populations. Aims: To assess nationwide population adults ≥65 old and to determine impact duration electrocardiogram (ECG) monitoring on number newly detected episodes. Methods: The NOMED-AF study (ClinicalTrials.gov; NCT: 0324347) was...

10.33963/kp.a2022.0202 article EN Kardiologia Polska 2023-01-31

Abstract Aims The coronavirus disease‐2019 (COVID‐19) pandemic has changed the landscape of medical care delivery worldwide. We aimed to assess influence COVID‐19 on hospital admissions and in‐hospital mortality rate in patients with acute heart failure (AHF) a retrospective, multicentre study. Methods results From 1 January 2019 31 December 2020, total 101 433 were hospitalized 24 Cardiology Departments Poland. number admitted due AHF decreased by 23.4% from 9853 7546 2020 ( P < 0.001)....

10.1002/ehf2.13680 article EN cc-by-nc-nd ESC Heart Failure 2021-11-16

Although mortality in patients with acute myocardial infarction (MI) has decreased substantially over the last few decades many countries, MI remains a major threat to public health.To assess number and outcomes of hospitalized for Poland 2018 as well proportions participating cardiac rehabilitation undergoing invasive procedures following discharge.We used databases. We included all assessed event-free survival along uptake procedures, rehabilitation, consultations cardiologists.A total...

10.33963/kp.a2022.0058 article EN Kardiologia Polska 2022-04-29

The in-hospital mortality following myocardial infarction has decreased substantially over the last two decades in Poland. However, according to available evidence approximately every 10th patient discharged after (MI) dies during next 12 months. We identified most important barriers (e.g. insufficient risk factors control, and delayed cardiac rehabilitation, suboptimal pharmacotherapy, complete revascularisation) proposed a new nation-wide system of coordinated care MI. should consist four...

10.5603/kp.2016.0118 article EN Kardiologia Polska 2016-08-22

Mortality following discharge in myocardial infarction survivors remains high. Therefore, we compared outcomes participating and not a novel, nationwide managed care program for Poland.We used public databases. We included all patients hospitalized due to acute Poland between October 1, 2017 December 31, 2018. excluded from the analysis aged <18 years as well those who died during hospitalization or within 10 days hospital. All were prospectively followed. The primary end point was defined...

10.1161/circoutcomes.120.007800 article EN Circulation Cardiovascular Quality and Outcomes 2021-08-01

It is the statement of Polish Experts on group patients that might benefit most from inclisiran. We indicated fastest way to have inclisiran available for polish patients, with necessary changes existing drug program PCSK9 inhibitors (B-101), explaining why it optimal way, and why, taking into account EBM data (the ORION program), should be added this program. also present some perspective future in availability innovative therapies such us targeted therapy, what, effectiveness LDL-C goal...

10.5114/aoms/147435 article EN cc-by-nc-sa Archives of Medical Science 2022-03-17

Effective ECG monitoring to detect silent atrial fibrillation 1 patients with AF/AFL. 1,2Although the incidence of AF/AFL is high, methods used diagnose AF/AFL, especially in clinically AF (SAF) are still expensive, and therefore their routine use medical practice limited. 3INTRODUCTION Atrial (AF) flutter (AFL) most common arrhythmias worldwide increases age.Stroke, heart failure, increased mortality serious complications

10.20452/pamw.16450 article EN Polskie Archiwum Medycyny Wewnętrznej 2023-02-28

To report acute and mid-term electrocardiographic changes in patients with hypertrophic obstructive cardiomyopathy (HOCM) after alcohol ablation of the first large septal branch left anterior descending coronary artery; to relate data ventricular outflow tract pressure gradients.Nine consecutive symptomatic HOCM (mean (SD) age 45 (12) years).Analysis baseline post-procedure ECGs 24 hour ambulatory monitoring (up six months). ECG were related gradients.One patient developed complete...

10.1136/hrt.80.3.257 article EN Heart 1998-09-01

Abstract Background The global burden of atrial fibrillation (AF) and diabetes mellitus (DM) is constantly rising, leading to an increasing healthcare stroke. AF often remains undiagnosed due the occurrence in asymptomatic, silent form, i.e., (SAF). study aims evaluate relationships between DM prevalence using a mobile long-term continuous ECG telemonitoring vest representative Polish European population ≥ 65 years for detection AF, symptomatic or silent. Methods A sample 3014 participants...

10.1186/s12933-021-01318-2 article EN cc-by Cardiovascular Diabetology 2021-06-24

Due to the unpredictable nature of COVID-19, there is a need identify patients at high risk severe course disease and higher mortality rate.

10.3390/ijerph19031104 article EN International Journal of Environmental Research and Public Health 2022-01-19

Conduction disturbances, aortic incompetence, and myocardial fibrosis are known complications in adult patients with ankylosing spondylitis (AS). Its incidence has been reported to be 10% 30%; however, less attention paid all cardiac arrhythmias. The aim of this study was evaluate arrhythmias conduction disturbances AS using electrocardiograms Holter monitoring (including heart rate variability analysis) estimate its relationships age, gender, clinical features, duration AS. Thirty-one (20...

10.1177/0003319707299208 article EN Angiology 2007-11-07

Summary We have demonstrated previously that histone deacetylase (HDAC6) expression is increased in animal models of systemic lupus erythematosus (SLE) and inhibition HDAC6 decreased disease. In our current studies, we tested if an orally active selective inhibitor would decrease disease pathogenesis a mouse model with established early Additionally, sought to delineate the cellular molecular mechanism(s) action SLE. treated 20-week-old (early-disease) New Zealand Black (NZB)/White F1 female...

10.1111/cei.13046 article EN Clinical & Experimental Immunology 2017-09-06

Permanent cardiac pacing is a recognized method of treatment patients with sick sinus syndrome and/or atrioventricular conduction disturbances. Implantation traditional systems transvenous leads associated risk complications, such as pneumothorax perforation wall or device related infection. An alternative that may be used for permanent represented by the leadless pacemaker, implanted directly into target chamber. Such devices have been in Poland since 2016, but number procedures limited due...

10.33963/kp.15982 article EN Kardiologia Polska 2021-04-29

Background: Silent atrial fibrillation (SAF) is common and associated with poor outcomes. Aims: to study the risk factors for AF SAF in elderly (≥65 years) general population develop a stratification model predicting SAF. Methods: Continuous ECG monitoring was performed up 30 days using vest-based system cohort from NOMED-AF, cross-sectional based on nationwide sample. The independent were determined multiple logistic regression. ROC analysis applied validate developed score. Results: From...

10.3390/jcm10112321 article EN Journal of Clinical Medicine 2021-05-26

Patients with severe symptomatic aortic stenosis have a poor prognosis medical management alone, and surgical valve replacement can improve symptoms survival. In recent years, transcatheter implantation (TAVI) has been demonstrated to survival in inoperable patients be an alternative treatment whom the risk of morbidity or mortality is high intermediate. A representative expert committee, summoned by Association Cardiovascular Interventions Polish Cardiac Society (ACVI) Cardio-Thoracic...

10.5603/kp.2017.0175 article EN Kardiologia Polska 2017-09-08

<h3>Objective</h3> To study differences between repetitive monomorphic ventricular tachycardia (RMVT) of right origin, and in arrhythmogenic dysplasia (ARVD). <h3>Patients</h3> Consecutive groups with RMVT (n = 15) or ARVD 12), comparable for age function. <h3>Methods</h3> Analysis baseline, tachycardia, signal averaged ECGs, clinical data, endomyocardial biopsies. Pathological findings were related to regional depolarisation (QRS width) repolarisation (QT interval, QT dispersion)....

10.1136/hrt.79.4.388 article EN Heart 1998-04-01

Heart failure has becoming an increasing medical, economic, and social problem globally. The prevalence of this syndrome is rising, despite unequivocal positive effects modern therapy, reduction mortality been achieved at the cost more frequent hospitalisations. Unlike in many European countries, Poland heart usually recognised later, a advanced stage disease, leaving less time for ambulatory treatment resulting high number current paper presents most important data regarding morbidity due...

10.5603/kp.2018.0050 article EN Kardiologia Polska 2018-02-16

REPORT ERT in Fabry disease Poland 91 associated with thin nerve fiber involvement occur, such as impaired perspiration (hypohidrosis, anhidrosis), abdominal pain, and diarrhea.Characteristic symptoms of the classic form also include angiokeratoma-type cutaneous lesions corneal opacities (cornea verticillata). 1 Even childhood, clinically silent proteinuric chronic kidney (CKD) may occur microalbuminuria or glomerulosclerosis.Multiorgan FD usually appear young adults CKD, left ventricular...

10.20452/pamw.15117 article EN Polskie Archiwum Medycyny Wewnętrznej 2019-12-20
Coming Soon ...